News

Early Bird Interest for OCRA’s Staying Connected: Summer Series

OCRA is thrilled to announce a special summer series in addition to our year-round Staying Connected virtual support group programming. A full schedule is listed below. Registration is required to participate…

Read on

Bring Ovarian Cycle to Your Community

Read on

Martin Cannon, PhD | Meet a Scientist

Dr. Martin Cannon, of University of Arkansas for Medical Sciences (UAMS), is a 2021 recipient of OCRA’s Collaborative Research Development Grant…

Read on

The Overview: May 2022

May has been officially recognized as National Cancer Research Month. Of course, at OCRA, every month is research month…

Read on

Watch Now: What’s New in Ovarian Cancer Research and Treatment

Many exciting updates about progress against ovarian cancer were presented at this year’s Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer — the largest meeting of gynecologic cancer experts in the world…

Read on

First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer

The following is a press release from Ovarian Cancer Research Alliance and Cancer Research Institute: Patients with ovarian cancer of the high-grade serous carcinoma subtype and that no longer respond to treatment with platinum-based therapy will…

Read on

New Ways to Build Community and Broaden Your Support System this Summer

As the busy summer months approach, OCRA remains committed to expanding support and offering new opportunities for our community to engage with others impacted by ovarian or other gynecologic cancers…

Read on

Urgent: Tell Your Senators to Increase Ovarian Cancer Research Funding

Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we asked for our community’s help in collecting…

Read on

Making a Difference in the Name of Mom

Mother’s Day signifies so much to so many—celebration, gratitude, and yes, remembrance or loss…

Read on

OCRA-Funded Study Pinpoints Partner Proteins That May Contribute to Ovarian Cancer Tumor Growth

The interaction between two partner proteins may promote the growth of the most common ovarian cancer subtype, according to recent findings from OCRA-funded researchers at University of Pennsylvania and Cedars-Sinai Medical Center and their…

Read on

New Immunotherapy Combination May Help Combat Ovarian Cancer Tumors

A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, of the University of California, San…

Read on

OCRA in Conversation: Dr. Richard Pazdur, FDA

Audra Moran, President and CEO of OCRA, and Dr. Richard Pazdur, Head of the Oncology Center of Excellence at FDA, shared reflections — both personal and professional — about ovarian cancer during a recent discussion…

Read on
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]